Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment

Journal of Otolaryngology

Volumn 35, Issue 3, 2006, Pages 157-166

  Balys, Richard ^a   Alaoui Jamali, Moulay ^a,c   Hier, Michael ^a,b   Black, Martin ^a,b   Domanowski, Gerard ^a   Rochon, Louise ^a   Jie, Su ^c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Mouse model; Oral cancer; Proteomics

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER TRANSPLANTATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL RESEARCH; METASTASIS; MOUSE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; SCID MOUSE; SQUAMOUS CELL CARCINOMA; TONGUE; XENOGRAFT;

AGED; ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; TONGUE NEOPLASMS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS;

EID: 33745210523     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2005.0032     Document Type: Article

References (32)

1. Reid BC, Winn DM, Morse DE, Pendrys DG. Head and neck in situ carcinoma: incidence, trends, and survival. Oral Oncol 2000;36:414-20.
2. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-40.
3. Yeatman TJ. The future of cancer management: translating the genome, transcriptome, and proteome (educational review). Ann Surg Oncol 2003;10:7-14.
4. Jones MB, Krutzsch H, Shu H, et al. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Protemics 2002;2:76-84.
5. Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-8.
6. Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004;15:24-30.
7. Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36-44.
8. Zhang A, Bast RC, Yu Y, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-90.
9. Diamandis E. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004;96:353-6.
10. Bankert RB, Hess SD, Egilmez NK. SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. Front Biosci 2002;7:c44-62.
11. Croy BA, Linder KL, Yager JA. Primer for non-immunologists on immune-deficient mice and their applications in research. Comp Med 2001;51:300-13.
12. Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999;17:279-84.
13. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6;17-32.
14. Williams SS, Alosco TR, Croy BA, Bankert RB. The study of human neoplastic disease in severe combined immunodeficient mice. Lab Anim Sci 1993;43:139-45.
15. Flanagan SP. "Nude", a new hairless gene with pleiotrophic effects in the mouse. Genet Res Camb 1966;8:295-309.
16. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodefiency mutation in the mouse. Nature 1983;301:527-30.
17. Goldman JP, Blundel LL, Kinnon C, et al. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor ãchain. Br J Haematol 1998;103:335-42.
18. Atillasoy ES, Elenitsas R, Sauter ER, et al. UVB induction of epithelial tumors in human skin using a RAG-1 mouse xenograft model. J Invest Dermatol 1997;109:704-9.
19. Lotzova E, Savary CA, Pollack SB. Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum. Transplantation 1983;35:490-4.
20. Tiberghien P, Longo DL, Wine JW, et al. Anti-sialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hemopoietic recovery. Blood 1990;76:1419-30.
21. Greiner DL, Shultz LD, Yates J, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. Am J Pathol 1995;146:888-902.
22. Danska JS, Pflumio F, Williams CJ, et al. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 1994;266:450-5.
23. Reuther T, Kubler AC, Staff CJ, et al. The RAG 2 mouse model for xenografted human oral squamous cell carcinoma. Lab Anim Sci 2002;41:31-5.
24. Leonard WJ, Noguchi M, Russell SM, McBride OW. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, yc. Immunol Rev 1994;138:61-86.
25. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002;100:3175-82.
26. Greenberg LH, Slayden OD. Human endometriotic xenografts in immunodeficient RAG2/γ(c) KO mouse. Am J Obstet Gynecol 2003;190:1788-96.
27. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17-32.
28. Qiu C, Hong W, Huajun H, Wiu W. A cervical lymph node metastatic model of human tongue carcinoma: serial and orthotopic transplantation of histologically intact patient specimens in nude mice. J Oral Maxillofac Surg 2003;61:696-700.
29. Umeda M, Yokoo S, Komori T, et al. Experimental model of invasion and metastasis by orthotopic transplantation of oral squamous and adenoid cystic carcinomas into the tongue of nude mice. Br J Oral Maxillofac Surg 2001;39:376-80.
30. Moriyama M. Development of diffuse invasive (grade 4D) human oral squamous cell carcinoma model in severe combined immunodeficiency mice: microangioarchitectural analysis and immunohistochemical study. Oral Oncol 1999; 35:395-400.
31. Ji ZW, Oku N, Umeda M, Komori T. Establishment of an oral squamous cell carcinoma cell line (NOS-1) exhibiting amplification of the erb B-1 oncogene and point mutation of 53 tumor suppressor gene: its biological characteristics and animal model of local invasion by orthotopic transplantation of the cell line. Oral Oncol 2001;37:386-92.
32. Kurokawa H, Katsube K, Podyma K, et al. Heparanase and tumor invasion patterns in human oral squamous cell carcinoma xenografts. Cancer Sci 2003;94:277-85.